Telemonitoring in heart failure: a multicentre randomised trial

Heart Centre Hasselt vzw (Belgium)0 个研究点目标入组 160 人开始时间: 2010年2月9日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Patients hospitalised for decompensated heart failure, necessitating intravenous (IV) diuretics or augmentation of oral (PO) diuretic, IV inotropic or IV vasodilator. Patients should be stabilised with treatment including angiotensin converting enzyme (ACE) inhibitors (or angiotensin II receptor antagonists [AIIA]), betablockers and diuretics at discharge.
•2. Patients should be capable of understanding the aims of the study and to use the telemonitoring system
•3. Aged between 50 and 85 years, either sex

•1. Reversible forms of heart failure
•2. Heart failure due to aortic stenosis
•3. Isolated right heart failure
•4. Patients residing in elderly homes
•5. Severe renal disease (glomerular filtration rate [GFR] less than 20 ml/min), planned dialysis in the next 6 months
•6. Planned implantation of biventricular pacemaker, or cardiac surgery
•7. Life expectancy less than 1 year
•8. Severe pulmonary disease

发起方

Heart Centre Hasselt vzw (Belgium)